Orbital Mucosa-Associated Lymphoid Tissue Lymphoma and Primary Cutaneous Classical Hodgkin Lymphoma: A Rare Case Report and Review of the Literature

Table 1

Current reported cases of primary cutaneous classical Hodgkin lymphoma, summarized from Koch et al. [3] and Kerstetter [2] with additions.

Reference	Age/sex (M)	PMHx requiring IS	Disease site	Therapy	Outcome	EBV
Idiopathic
[9]	50	None	Chest wall	MOPP-ABVD	Systemic disease after 2 months	N/A
	54	None	Left lower leg	RT	Systemic progression after 6 years	N/A
	45	None	Forearms and legs	Multiple chemotherapy	No progression at 5 years postchemo	N/A
	17	None	Right thigh	Topical CT	No progression at 9 years	N/A
	52	None	Right arm	None	No progression at 9 years	N/A
[10]	86	None	Left ankle	RT	Systemic disease discovered after 1 year	N/A
[11]	59	None	Left flank, inner thigh, and right foot	ABVD	No progression at 3 years	N/A
[12]	70	None	Right back	RT	No progression at 7 years	Negative
[3]	49	None	Right forearm	ABVD	Response to treatment but passed away from pulmonary tuberculosis	Negative
[13]	80	None	Left thigh	ABVD	No long-term follow-up data	N/A
Iatrogenic
[14]	74	UC on infliximab	Scalp	Withholding immunosuppression, excision and chemo	Disease free at 10 months	Positive
[10]	25	DM, on MTX/thalidomide/steroids	Scalp	Withholding immunosuppression, chemo & radiation	Complete remission at 6 years	Positive
[2]	58	DM, on MTX/CellCept/steroids	Elbow	Withholding immunosuppression, excision	Recurrence after 13 months	Positive

IS, immunosuppression; MOPP, mechlorethamine, vincristine, procarbazine, prednisone; ABVD, adriamycin, bleomycin, vinblastine, dacarbazine; RT, radiation therapy; CT, corticosteroids; UC, ulcerative colitis; DM, dermatomyositis; MTX, methotrexate; N/A, status not available.